GDP (Good Distribution Practice)

TitlePublisherIssue DateFiles
EC
EU Good Distribution Practice of Medicinal Products for Human Use (2013/C 343/01)ECNov-2013English
EU Good Distribution Practice of Active Substances for Medicinal Products for Human Use ( 2015/C 95/01 )ECMar-2015English
HPRA
HPRA Guide to Good Distribution Practice of Medicinal Products for Human Use (9 MAY 2019)HPRAMay-2019English
MHRA
Exceptional good distribution practice (GDP) flexibilities for medicines during the coronavirus (COVID-19) outbreakMHRAApr-2020na
US FDA
Guidance for Industry, Product Identifier Requirements Under the Drug Supply Chain Security Act - Compliance PolicyUS FDASep-2018English
WHO
WHO Good Trade and Distribution Practices for Pharmaceutical Starting Materials. WHO Technical Report Series, No. 996, 2016, Annex 6WHO2016English
WHO Good Distribution Practices for Pharmaceutical Products. WHO Technical Report Series, No. 957, 2010, Annex 5WHO2010English
WHO Guide to good storage practices for pharmaceuticals. WHO Technical Report Series, No. 908, 2003, Annex 9WHO2003English

GMP (Good Manufacturing Practice)

TitlePublisherIssue DateFiles
EC
EU GMP Annex 13: Investigational Medicinal ProductsECFeb-2010English
EMA
ICH Q7 Good manufacturing practice for active pharmaceutical ingredientsEMA2000English
US FDA
Guidance for Industry, Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical IngredientsUS FDASep-2016English
WHO
WHO Starting Materials for Pharmaceutical Products: Control and Safe TradeWHO1998English
WHO Pharmaceutical Starting Materials Certification Scheme (SMACS): Guidelines on Implementation. WHO Technical Report Series, No. 917, 2003, Annex 3WHO2003English
Good Manufacturing Practices: Supplementary Guidelines for the Manufacture of Pharmaceutical Excipients. WHO Technical Report Series, No. 885, 1999, Annex 5WHO1999English

COVID-19

TitlePublisherIssue DateFiles
EMA
Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemicEMAMar-2020English
US FDA
FDA Issues Guidance for Conducting Clinical TrialsUS FDAMar-2020English
WHO
WHO Country & Technical Guidance - Coronavirus disease (COVID-19)WHOMar-2020English